{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:21:03Z","timestamp":1761016863294,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/bf03190029","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T02:01:31Z","timestamp":1280887291000},"page":"255-264","source":"Crossref","is-referenced-by-count":10,"title":["Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat"],"prefix":"10.1007","volume":"24","author":[{"given":"S.","family":"Nagaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ratnaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03190029_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","volume":"313","author":"R.H. Mattson","year":"1985","unstructured":"Mattson R.H., Cramer J.A., Collins J.F. (1985): Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalised tonic clonic seizures. N. Engl. J. Med., 313: 145\u2013151.","journal-title":"N. Engl. J. Med."},{"key":"BF03190029_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1600-0404.1967.tb05737.x","volume":"43","author":"O.V. Olesen","year":"1967","unstructured":"Olesen O.V., Dam M. (1967): The metabolic conversion of primidone (Mysoline) to phenobarbitone in patients under long-term treatment. Acta Neurol. Scand., 43: 348\u2013356.","journal-title":"Acta Neurol. Scand."},{"key":"BF03190029_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-3565(25)29595-7","volume":"186","author":"I.P. Baumel","year":"1973","unstructured":"Baumel I.P., Gallagher B.B., Di Micco J., Goico H. (1973: Metabolism and anticonvulsant properties of primidone in the rat. J. Pharmacol. Exp. Ther., 186: 305\u2013314.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190029_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archneur.1972.00490130036005","volume":"27","author":"I.P. Baumel","year":"1972","unstructured":"Baumel I.P., Gallagher B.B., Mattson R. (1972): Phenylethylmalonamide. An important metabolite of primidone. Arch. Neurol., 27: 34\u201341.","journal-title":"Arch. Neurol."},{"key":"BF03190029_CR5","first-page":"14","volume":"242","author":"H.H. Frey","year":"1979","unstructured":"Frey H.H., Gobel W., Loscher W. (1979): Pharmacokinetics of primidone and its active metabolites in the dog. Arch. Int. Pharmacol., 242: 14\u201330.","journal-title":"Arch. Int. Pharmacol."},{"key":"BF03190029_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000137981","volume":"28","author":"H.H. Frey","year":"1984","unstructured":"Frey H.H., Loscher W., Reiche R., Schultz D. (1984): Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Pharmacology, 28: 329\u2013335.","journal-title":"Pharmacology"},{"key":"BF03190029_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1139\/y78-100","volume":"56","author":"D.D. Johnson","year":"1978","unstructured":"Johnson D.D., Davis H.L., Crawford R.D. (1978): Epileptiform seizures in domestic fowl. VIII. Anticonvulsant activity of primidone and its metabolites, phenobarbital and phenylethylmalonamide. Can. J. Physiol. Pharmacol., 56: 630\u2013633.","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BF03190029_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.410050512","volume":"5","author":"K.W. Leal","year":"1979","unstructured":"Leal K.W., Rapport R.L., Wilensky A.J., Friel P.N. (1979): Single dose pharmacokinetics and anticonvulsant efficacy of primidone in mice. Ann. Neurol., 5: 470\u2013474.","journal-title":"Ann. Neurol."},{"issue":"Suppl 3","key":"BF03190029_CR9","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1111\/j.1528-1157.1987.tb05778.x","volume":"28","author":"D.B. Smith","year":"1987","unstructured":"Smith D.B., Mattson R.H., Cramer J.A., Collins J.F., Novelly R.A., Craft B. (1987): Results of a nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin and primidone. Epilepsia, 28 (Suppl 3): S50-S58.","journal-title":"Epilepsia"},{"key":"BF03190029_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneur.1966.00470070035004","volume":"14","author":"P.T. White","year":"1966","unstructured":"White P.T., Plott D., Norton J. (1966): Relative anticonvulsant potency of primidone. A double blind comparison. Arch. Neurol. 14: 31\u201335.","journal-title":"Arch. Neurol."},{"key":"BF03190029_CR11","first-page":"237","volume-title":"Antiepileptic Therapy: Advances in drug monitoring","author":"J. Oxley","year":"1980","unstructured":"Oxley J., Hebdige S., Luidlaw J., Wadsworth J., Richens A. (1980): A comparison of phenobarbitone and primidone in the treatment of epilepsy. In: Johannessen, S.I.et al. Eds. Antiepileptic Therapy: Advances in drug monitoring. New York: Raven, 237\u2013245."},{"key":"BF03190029_CR12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1212\/WNL.33.3.291","volume":"33","author":"B.F.D. Bourgeois","year":"1983","unstructured":"Bourgeois B.F.D., Dodson W.E., Ferrendelli J.A. (1983): Primidone, phenobarbital and PEMA: II. Seizure protection, neurotoxicity and therapeutic index of varying combinations in mice. Neurology, 33: 291\u2013295.","journal-title":"Neurology"},{"key":"BF03190029_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0014-2999(89)90294-X","volume":"162","author":"W. Loscher","year":"1989","unstructured":"Loscher W., Honack D. (1989): Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. Eur. J. Pharmacol., 162: 309\u2013322.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03190029_CR14","first-page":"713","volume-title":"Basic mechanisms of the epilepsies. Molecular and cellular approaches. Advance in Neurology","author":"R.L. Macdonald","year":"1986","unstructured":"Macdonald R.L., McLean M.J. (1986): Anticonvulsant drugs: mechanisms of action, In: Delgado-Escueta A.V., Ward A.A., Woodbury D.M., Porter R.J. eds. Basic mechanisms of the epilepsies. Molecular and cellular approaches. Advance in Neurology Vol 44. New York: Raven Press, 713\u2013725."},{"key":"BF03190029_CR15","first-page":"325","volume":"391","author":"R.M. McClain","year":"1995","unstructured":"McClain R.M. (1995): Phenobarbital mouse liver tumors: implications of hepatic tumour promotion for cancer risk assessment. Prog. Clin. Biol. Res., 391: 325\u2013336.","journal-title":"Prog. Clin. Biol. Res."},{"issue":"Suppl. 12","key":"BF03190029_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/em.2850110602","volume":"11","author":"E. Zeiger","year":"1988","unstructured":"Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K. (1988):Salmonella mutagenicity tests: IV. Results from testing 300 chemicals. Environ. Mol. Mutagene., 11 (Suppl. 12): 1\u2013158.","journal-title":"Environ. Mol. Mutagene."},{"key":"BF03190029_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00613432","volume":"9","author":"G.W. Houghton","year":"1975","unstructured":"Houghton G.W., Richens A., Toseland P.A., Davidson S., Falconer M.A. (1975): Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients. Eur. J. Clin. Pharmacol., 9: 73\u201378.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF03190029_CR18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.22.8.841","volume":"22","author":"E.H. Reynolds","year":"1972","unstructured":"Reynolds E.H., Mattson R.H., Gallagher B.B. (1972): Relationship between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients. Neurology, 22: 841\u2013844.","journal-title":"Neurology"},{"key":"BF03190029_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1528-1157.1975.tb04758.x","volume":"16","author":"D. Schmidt","year":"1975","unstructured":"Schmidt D., Kupferberg H.S. (1975): Diphenylhydantoin, phenobarbital and primidone in saliva, plasma and cerebrospinal fluid. Epilepsia, 16: 735\u2013741.","journal-title":"Epilepsia"},{"key":"BF03190029_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1528-1157.1975.tb06051.x","volume":"16","author":"A.S. Troupin","year":"1975","unstructured":"Troupin A.S., Friel P. (1975): Anticonvulsant levels in saliva, serum and cerebrospinal fluid. Epilepsia, 16: 223\u2013227.","journal-title":"Epilepsia"},{"key":"BF03190029_CR21","first-page":"365","volume":"61","author":"G.F. Carl","year":"1988","unstructured":"Carl G.F., Smith M.L. (1988): Chronic primidone treatment in the rat: An animal model of primidone therapy. Res. Commun. Chem. Pathol. Pharmacol., 61: 365\u2013379.","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"BF03190029_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/1056-8719(92)90061-5","volume":"28","author":"P.N. Patsalos","year":"1992","unstructured":"Patsalos P.N., Alavijeh M.S., Semba J., Lolin Y.I. (1992): A freely moving and behaving rat model for the chronic and simultaneous study of drug pharmacokinetics (blood) and neuropharmacokinetics (cerebrospinal fluid): hematological and biochemical characterization and kinetic evaluation using carbamazepine. J. Pharmacol. Toxicol. Methods, 28: 21\u201328.","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"BF03190029_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-3565(25)21911-5","volume":"29","author":"M. Danhof","year":"1984","unstructured":"Danhof M., Levy G. (1984): Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex. J. Pharmacol. Exp. Ther., 29: 44\u201350.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190029_CR24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0022-3565(25)24592-X","volume":"244","author":"P.M. Klockowski","year":"1988","unstructured":"Klockowski P.M., Levy G. (1988): Kinetics of drug action in disease states. XXIV. Pharmacodynamics of diazepam and its active metabolites in rats. J. Pharmacol. Exp. Ther., 244: 912\u2013918.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190029_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/jps.2600780604","volume":"78","author":"I. Ramzan","year":"1989","unstructured":"Ramzan I., Levy G. (1989): Relationship between concentration and anticonvulsant effect of phenytoin against electroshock-induced seizures in rats: Comparison of sampling sites for concentration determinations. J. Pharm. Sci., 78: 448\u2013451.","journal-title":"J. Pharm. Sci."},{"key":"BF03190029_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0028-3908(88)90150-5","volume":"27","author":"E.N. Sokomba","year":"1988","unstructured":"Sokomba E.N., Patsalos P.N., Lolin Y.I., Curzon G. (1988): Concurrent monitoring of central carbamazepine and transmitter amine metabolism and motor activity in individual unrestrained rats using repetitive withdrawal of cerebrospinal fluid. Neuropharmacology, 27: 409\u2013415.","journal-title":"Neuropharmacology"},{"key":"BF03190029_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0920-1211(94)90020-5","volume":"19","author":"Y.I. Lolin","year":"1994","unstructured":"Lolin Y.I., Ratnaraj N., Hjelm M., Patsalos P.N. (1994): Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin. Epilepsy Res., 19: 99\u2013110.","journal-title":"Epilepsy Res."},{"key":"BF03190029_CR28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1476-5381.1993.tb13514.x","volume":"108","author":"J. Semba","year":"1993","unstructured":"Semba J., Curzon G., Patsalos P.N. (1993): Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide. Br. J. Pharmacol., 108: 1117\u20131124.","journal-title":"Br. J. Pharmacol."},{"key":"BF03190029_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1528-1157.1998.tb01374.x","volume":"39","author":"M.C. Walker","year":"1998","unstructured":"Walker M.C., Tong X., Brown S., Shorvon S.D., Patsalos P.N. (1998): Comparison of single- and repeated-dose pharmacokinetics of diazepam. Epilepsia, 39: 283\u2013289.","journal-title":"Epilepsia"},{"key":"BF03190029_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0920-1211(98)00104-1","volume":"34","author":"H.C. Doheny","year":"1999","unstructured":"Doheny H.C., Ratnaraj N., Whittington M.A., Jefferys J.G.R., Patsalos P.N. (1999): Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat. Epilepsy Res., 34: 161\u2013168.","journal-title":"Epilepsy Res."},{"key":"BF03190029_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0009-9120(89)80096-7","volume":"22","author":"N. Ratnaraj","year":"1989","unstructured":"Ratnaraj N., Goldberg V.D., Hjelm M. (1989): A micromethod for the estimation of free levels of anticonvulsant drugs in serum. Clin. Biochem., 22: 443\u2013450.","journal-title":"Clin. Biochem."},{"key":"BF03190029_CR32","volume-title":"A manual for PCNONLIN","author":"C.M. Metzler","year":"1988","unstructured":"Metzler C.M., Weiner D.L. (1988): A manual for PCNONLIN, Statistical Consultants, Lexington, KY., USA."},{"key":"BF03190029_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0169-2607(85)90085-9","volume":"20","author":"A.A. Dunn","year":"1985","unstructured":"Dunn A.A. (1985): A new iterative polyexponential curve fitting program. Comput. Methods Prog. Biomed., 20: 269\u2013275.","journal-title":"Comput. Methods Prog. Biomed."},{"key":"BF03190029_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1528-1157.1984.tb04199.x","volume":"25","author":"W. Loscher","year":"1984","unstructured":"Loscher W., Frey H.H. (1984): Kinetics of penetration of common antiepileptic drugs into cerebrospinal fluid. Epilepsia, 25: 346\u2013352.","journal-title":"Epilepsia"},{"key":"BF03190029_CR35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3565(25)27880-6","volume":"159","author":"J.M. Fujimoto","year":"1968","unstructured":"Fujimoto J.M., Mason W.H., Murphy M. (1968): Urinary excretion of primidone and its metabolites in rabbits. J. Pharmacol. Exp. Ther., 159: 379\u2013388.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190029_CR36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0090-9556(25)06325-1","volume":"6","author":"R.J. Hunt","year":"1978","unstructured":"Hunt R.J., Miller K.W. (1978): Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit. Drug Metab. Dispos. 6: 75\u201381.","journal-title":"Drug Metab. Dispos."},{"key":"BF03190029_CR37","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/0006-2952(84)90345-9","volume":"33","author":"M. Holler","year":"1984","unstructured":"Holler M., Penin H. (1984): Studies on the intracerebral metabolism of anticonvulsant drugs \u2014 I. Perfusion of primidone through the isolated brain of the rat. Biochem. Pharmacol., 33: 1753\u20131756.","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03190029\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:33:43Z","timestamp":1740339223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03190029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["BF03190029"],"URL":"https:\/\/doi.org\/10.1007\/bf03190029","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}